Source: The Indian Serum Institute reports vaccine shipments to 3 countries, including two Arab countries



[ad_1]

Source: The Indian Serum Institute reports vaccine shipments to 3 countries, including two Arab countries

A knowledgeable source said the Indian Serum Institute for Serum and Vaccine has notified 3 countries that upcoming supplies of AstraZeneca Corona vaccine will be delayed due to strong domestic demand.

An informed source added to “Reuters” that the Indian Serum Institute for Serum and Vaccine has informed Saudi Arabia, Morocco and Brazil that supplies from the AstraZeneca vaccine against Covid-19 will be delayed due to due to strong domestic demand (in India), while the institute is striving to increase its capacity.

The delay comes at a time when authorities in India, the world’s largest vaccine producer, face local criticism for donating or selling vaccines, overtaking vaccination operations in the country, as the India records the highest number of Corona cases in the world. , after the United States and Brazil.

The disclosure of the new delay in vaccine shipments came days after Britain announced it would slow the pace of the vaccination program next month as the Indian Serum Institute is expected to deliver supplies later than planned.

India is currently experiencing a second wave of Corona injuries, which has led to an increase in the total number of injuries to around 11.6 million.

The Serum Institute provided half of the 10 million doses recently ordered by Great Britain.

India’s foreign ministry says Brazil has received four million doses from the institute, Saudi Arabia has received three million doses and Morocco has received seven million doses. The three countries had requested 20 million doses.

The institute has partnered with AstraZeneca (the British Swedish company), the Gates Foundation and the Global Vaccine Alliance, to manufacture up to a billion doses to supply poor countries.

To date, India has donated 8 million doses and sold around 52 million doses to 75 countries, the majority of which are from the AstraZeneca vaccine made at the Serum Institute. India has used more than 44 million doses since the start of its vaccination campaign in mid-January.

Source: Reuters



[ad_2]
Source link